We aimed to evaluate the site-specific incidence of cancer in patients with T2DM-treated GLP-1 RAs using a nationwide cohort
Semaglutide could ultimately be a valuable pharmacological alternative or add-on to these medications, however, more studies are needed to determine the efficacy of this drug, as well as its safety in people with average and below average BMI for whom weight loss could cause medical problems
One particularly noteworthy association that stood out is the significant risk reduction across multiple gastrointestinal cancers, including colorectal, esophageal, stomach, gallbladder, liver and pancreatic cancers, Wang said
Thanks, everyone, for all your suggestions and advice
Hospital for Special Surgery